Bestseller
FOR ADULT ACNE-PRONE SKIN
Persistent imperfections and marks. Visible pores.

Specifically adapted and well-tolerated for acne-prone skin. 
Non-comedogenic.

Tested on acne-prone skin. Avoid eye area. In contact with eyes, rinse thoroughly. Use in association with a daily photo-protection product (SPF > 15). Do not apply on open scars.

Validity after opening:
12 Months
  • Bottle
  • Adults
  • Anti-imperfection
    Anti-marks
    Anti-recurrence 
  • Face
Volume
3337875598071

40 ml

bag

IT'S PROVEN
IMMEDIATE AND DURABLE EFFICACY

PictoChrono

HIGH CLINICAL EFFICACY 
-45%
pimples*
-50% blackheads**
-49% marks*

Clinical test 51 women once daily application for 4 weeks. * After 28 days ** After 44 days

Bar

VISIBLE EFFICACY FROM THE FIRST MORNING
83%
Skin looks smoother and texture appears refined

EFFICACY IN 14 DAYS 
90% Fine lines are reduced 
100% The skin is comfortable 
92% Pores are less visible *

.
.

ACNE WONT DETERMINE
MY AMBITION

Discover the new ultra concentratedserum, your new daily peeling gesture for an anti-imperfection efficacy.

 

EXPERT
QUOTE

Avoid friction and scratching when cleansing or applying your skincare. Avoid touching skin as much as possible, keep nails short and avoid sun exposure, as it might worsen blemishes.

Sitecore CDO

THE PERFECT MATCH
FOR YOUR SKIN

EFFACLAR'S WINNING TRIO

EFFACLAR is a complete range of anti-imperfection solutions that targets all the stages of the imperfection life cycle with a high efficacy, while ensuring a perfect tolerance.

ACNE-PRONE SKIN
DIAGNOSIS

lrpspotscansitecoremobilebanner375x252pxzoe
POWERED BY AI

DISCOVER THE OTHER
PRODUCTS OF THE RANGE

EFFACLAR is a complete range of anti-imperfection solutions that targets all the stages of the imperfection life cycle with a high efficacy, while ensuring a tolerance.
Question mark icon

Did you
know?

woman holding a jar of La Roche-Posay Cicaplast Baume B5, with a blue background
The 3-step EFFACLAR routine – cleanse, correct, protect – shows proven effectiveness on patients with acne-prone skin living in polluted environments.*

*Quantitative study, Beijing/Shanghai, 2014, Total sample: n=600 ²DIM Sell-in YTD Sept 2015 ³INS/Kantar Health La Roche-Posay Barometers 2013